Theriva Biologics Inc (AMEX:TOVX) has a beta value of 1.38 and has seen 26.08 million shares traded in the last trading session. The company, currently valued at $5.96M, closed the last trade at $5.90 per share which meant it gained $1.2 on the day or 25.53% during that session. The TOVX stock price is -190.0% off its 52-week high price of $17.11 and 54.92% above the 52-week low of $2.66. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.42 million shares traded. The 3-month trading volume is 138.43K shares.
Theriva Biologics Inc (AMEX:TOVX) trade information
Sporting 25.53% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the TOVX stock price touched $5.90 or saw a rise of 17.48%. Year-to-date, Theriva Biologics Inc shares have moved -45.13%, while the 5-day performance has seen it change 63.89%. Over the past 30 days, the shares of Theriva Biologics Inc (AMEX:TOVX) have changed 8.16%. Short interest in the company has seen 3988.0 shares shorted with days to cover at 0.19.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Theriva Biologics Inc (TOVX) estimates and forecasts
The company’s shares have lost -52.30% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 51.06% over the past 5 years.
TOVX Dividends
Theriva Biologics Inc is expected to release its next earnings report in October this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Theriva Biologics Inc (AMEX:TOVX)’s Major holders
Insiders own 1.32% of the company shares, while shares held by institutions stand at 5.52% with a share float percentage of 5.59%. Investors are also buoyed by the number of investors in a company, with Theriva Biologics Inc having a total of 20.0 institutions that hold shares in the company.
